Tianshu Ren

898 total citations
26 papers, 633 citations indexed

About

Tianshu Ren is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Tianshu Ren has authored 26 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Physiology. Recurrent topics in Tianshu Ren's work include Plant-derived Lignans Synthesis and Bioactivity (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Mechanisms and Therapy (3 papers). Tianshu Ren is often cited by papers focused on Plant-derived Lignans Synthesis and Bioactivity (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Mechanisms and Therapy (3 papers). Tianshu Ren collaborates with scholars based in China, Brazil and United Kingdom. Tianshu Ren's co-authors include Qingchun Zhao, Yingshi Zhang, Fuhai Hui, Jiayi Cai, An Li, Hongda Ma, Qing‐Chun Zhao, Xing Tian, Mingyi Zhao and Jin Huang and has published in prestigious journals such as Scientific Reports, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Tianshu Ren

25 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianshu Ren China 12 246 117 99 87 65 26 633
Hongda Ma China 11 193 0.8× 101 0.9× 64 0.6× 67 0.8× 58 0.9× 18 567
Fan Feng China 14 264 1.1× 38 0.3× 88 0.9× 66 0.8× 14 0.2× 31 605
Jin‐Soo Kim Australia 16 200 0.8× 29 0.2× 119 1.2× 13 0.1× 88 1.4× 33 765
Tien‐Wei Hsu Taiwan 15 266 1.1× 13 0.1× 125 1.3× 58 0.7× 105 1.6× 53 727
Neslihan Aygün Kocabaş Türkiye 19 342 1.4× 16 0.1× 78 0.8× 55 0.6× 145 2.2× 55 1.0k
Yifei Ren China 17 222 0.9× 16 0.1× 45 0.5× 62 0.7× 147 2.3× 53 837
Petra Vinken Belgium 13 223 0.9× 39 0.3× 48 0.5× 14 0.2× 103 1.6× 31 663
Justin Miller United States 16 143 0.6× 93 0.8× 22 0.2× 99 1.1× 11 0.2× 30 676
Yuchi Zhang China 14 201 0.8× 32 0.3× 59 0.6× 39 0.4× 7 0.1× 46 553
Mümin Alper Erdoğan Türkiye 16 229 0.9× 21 0.2× 50 0.5× 49 0.6× 47 0.7× 98 775

Countries citing papers authored by Tianshu Ren

Since Specialization
Citations

This map shows the geographic impact of Tianshu Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianshu Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianshu Ren more than expected).

Fields of papers citing papers by Tianshu Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianshu Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianshu Ren. The network helps show where Tianshu Ren may publish in the future.

Co-authorship network of co-authors of Tianshu Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Tianshu Ren. A scholar is included among the top collaborators of Tianshu Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianshu Ren. Tianshu Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Bin, et al.. (2025). Association between alactic base excess on mortality in sepsis patients: a retrospective observational study. Journal of Intensive Care. 13(1). 20–20. 1 indexed citations
2.
3.
Zhang, Yingshi, Xiangbo Xu, Shuai Wang, et al.. (2024). The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis. European Journal of Pharmacology. 983. 176952–176952. 4 indexed citations
4.
Xu, Chang, Xudong Gao, Tianshu Ren, et al.. (2024). The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk. Pharmacological Research. 203. 107142–107142. 9 indexed citations
5.
Li, Xinzhu, Jiaqing Chen, Tianshu Ren, et al.. (2023). Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis. Medicine. 102(27). e34122–e34122. 11 indexed citations
6.
7.
Zhang, Tianqi, et al.. (2023). Addition of PI3K/AKT/mTOR inhibitors to fulvestrant for advanced HR+/HER2- breast cancer: a systematic review and meta-analysis. Future Oncology. 19(20). 1439–1450. 2 indexed citations
8.
Ren, Tianshu, Hui Jia, Qiong Wu, et al.. (2022). Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab. Frontiers in Oncology. 12. 829059–829059. 5 indexed citations
9.
Wang, Shu, Yingshi Zhang, Tianshu Ren, et al.. (2020). A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway. Cell Death and Disease. 11(6). 491–491. 26 indexed citations
10.
Yue, Yang, Huan Gao, Wenwu Liu, et al.. (2020). DCMQA, a caffeoylquinic acid derivative alleviates NMDA-induced neurotoxicity via modulating GluN2A and GluN2B-containing NMDA receptors in vitro. Toxicology in Vitro. 67. 104888–104888. 7 indexed citations
11.
Lu, Hongyuan, Yuxin Tan, Xiaochun Qin, et al.. (2020). Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Life Sciences. 244. 117343–117343. 33 indexed citations
12.
13.
Li, Dandan, Huaiwei Ding, Qiong Wu, et al.. (2018). A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5‐Fluorouracil by reversing Notch and epithelial‐mesenchymal transition in vitro and in vivo. Cell Proliferation. 51(5). e12480–e12480. 49 indexed citations
14.
Zhang, Yingshi, Qiyu Jiang, Shuang Cao, et al.. (2018). Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death and Disease. 9(7). 743–743. 93 indexed citations
15.
Hui, Fuhai, Yingshi Zhang, Tianshu Ren, et al.. (2018). Role of metformin in overweight and obese people without diabetes: a systematic review and network meta-analysis. European Journal of Clinical Pharmacology. 75(4). 437–450. 35 indexed citations
16.
Hui, Fuhai, Xiaochun Qin, Qiao Zhang, et al.. (2018). Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo. Biomedicine & Pharmacotherapy. 109. 2365–2374. 21 indexed citations
17.
Zhang, Yingshi, Jiayi Cai, Yaqiong Zhang, et al.. (2016). Improvement in Stroke-induced Motor Dysfunction by Music-supported Therapy: A Systematic Review and Meta-analysis. Scientific Reports. 6(1). 38521–38521. 36 indexed citations
18.
Tian, Xing, An Li, Jian Wang, et al.. (2015). Compound MQA, a Caffeoylquinic Acid Derivative, Protects Against NMDA‐Induced Neurotoxicity and Potential Mechanisms In Vitro. CNS Neuroscience & Therapeutics. 21(7). 575–584. 21 indexed citations
19.
Tian, Xing, Liping Guo, Xiaolong Hu, et al.. (2014). Protective Effects of Arctium lappa L. Roots Against Hydrogen Peroxide-Induced Cell Injury and Potential Mechanisms in SH-SY5Y Cells. Cellular and Molecular Neurobiology. 35(3). 335–344. 38 indexed citations
20.
Lv, Wenwen, et al.. (2014). Isoindolone derivative QSN-10c induces leukemic cell apoptosis and suppresses angiogenesis via PI3K/AKT signaling pathway inhibition. Acta Pharmacologica Sinica. 35(5). 625–635. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongda Ma Breakdown of academic impact, for papers by Fan Feng Breakdown of academic impact, for papers by Jin‐Soo Kim Breakdown of academic impact, for papers by Tien‐Wei Hsu Breakdown of academic impact, for papers by Neslihan Aygün Kocabaş Breakdown of academic impact, for papers by Yifei Ren Breakdown of academic impact, for papers by Petra Vinken Breakdown of academic impact, for papers by Justin Miller Breakdown of academic impact, for papers by Yuchi Zhang Breakdown of academic impact, for papers by Mümin Alper Erdoğan
Rankless by CCL
2026